SPAC Daily: FAZE Drops on Day-1

by | Jul 20, 2022

While the narrative hasn’t steadily improved for SPACs, it’s a good sign to see DeSPACs getting across the finish line, including some of the more high profile names. FaZe Holdings (FAZE) made their public debut today, and Getty Images (GETY) will debut next week. While FAZE fell today (some would say the stock was artificially high), time will ultimately tell on performance.

FAZE stock fell on its ticker change day

There have been just 4 DeSPACs to begin trading in July, and as such is helpful for the market supply to see some more get across the finish line. There are at least 3 more merger votes teed up for July at this point.

Elsewhere in SPACs

  • CC Neuberger Principal Holdings II (PRPB) announced that shareholders approved its Getty Images deal and that the stock will trade as GETY following closing on 7/25
  • Pagaya Technologies (PGY), which despac’ed back in June filed an F-1 which allowed (at long last) to back into its redemption numbers. The numbers make the SPAC one of the lowest floats out there at just over 900k public shares.
  • Fortune Rise Acquisition Corp. (FRLA) and crypto company VCV Technology became the latest SPAC to terminate their previously agreed upon combination. Just recently announced in May, the deal becomes a quick casualty of the so-called “Crypto Winter.” With both SPACs and crypto struggling, it will be tough to get those deals across the line.
  • Bloomberg is reporting that Turkish mobility company Marti is close to announcing an M&A deal with SPAC Galata Acquisition Corp. (GLTA)
  • Patrick Orlando’s Benessere Capital Acquisition Corp. (BENE) reported 3.4M shares redeemed as part of its latest extension vote.

Upcoming SPAC Calendar

Full calendar and SPAC database access here

Today’s Price Action

Biggest Gainers

4.30% ~ $ 10.43 | CLAY – Chavant Capital Acquisition Corp. (Pre-Deal)
3.10% ~ $ 10.49 | FOXW – FoxWayne Enterprises Acquisition Corp. (Pre-Deal)
1.96% ~ $ 30.15 | DWAC – Digital World Acquisition Corp. (Announced)
.80% ~ $ 10.10 | LJAQ – LIGHTJUMP ACQUISITION CORPORATION (Announced)
.62% ~ $ 9.73 | HWEL – Healthwell Acquisition Corp. I (Pre-Deal)
.61% ~ $ 9.91 | VBOC – Viscogliosi Brothers Acquisition Corp (Pre-Deal)
.60% ~ $ 10.07 | UPTD – TradeUP Acquisition Corp (Pre-Deal)
.51% ~ $ 9.84 | RACB – Research Alliance Corp. II (Pre-Deal)
.51% ~ $ 9.87 | TWNI – Tailwind International Acquisition Corp. (Pre-Deal)
.50% ~ $ 9.98 | SGHL – Signal Hill Acquisition Corp. (Pre-Deal)
.50% ~ $ 9.98 | CIIG – CIIG Capital Partners II, Inc. (Pre-Deal)
.50% ~ $ 9.99 | TGAA – Target Global Acquisition I Corp. (Pre-Deal)
.50% ~ $ 10.05 | SHAP – Spree Acquisition Corp. 1 Ltd (Pre-Deal)
.49% ~ $ 10.28 | ESSC – East Stone Acquisition Corporation (Announced)
.41% ~ $ 9.78 | FWAC – Fifth Wall Acquisition Corp. III (Pre-Deal)
.41% ~ $ 9.84 | CSLM – Consilium Acquisition Corp I, Ltd. (Pre-Deal)
.41% ~ $ 9.88 | MCAC – Monterey Capital Acquisition Corp (Pre-Deal)
.40% ~ $ 9.96 | NPAB – New Providence Acquisition Corp. II (Pre-Deal)
.40% ~ $ 9.98 | RCFA – RCF Acquisition Corp. (Pre-Deal)
.40% ~ $ 10.01 | DSAC – Duddell Street Acquisition Corp (Announced)

Biggest Losers

-22.96% ~ $ 7.82 | ACTD – ArcLight Clean Transition Corp. II (Announced)
-14.15% ~ $ 8.31 | PRPB – CC Neuberger Principal Holdings II (Announced)
-2.76% ~ $ 9.70 | NLIT – Northern Lights Acquisition Corp. (Announced)
-.80% ~ $ 9.94 | WQGA – World Quantum Growth Acquisition Corp (Pre-Deal)
-.60% ~ $ 9.93 | BLSA – BCLS Acquisition Corp. (Pre-Deal)
-.50% ~ $ 10.02 | FRBN – Forbion European Acquisition Corp. (Pre-Deal)
-.50% ~ $ 10.03 | CFVI – CF Acquisition Corp. VI (Announced)
-.40% ~ $ 9.84 | EPWR – Empowerment & Inclusion Capital I Corp (Pre-Deal)
-.40% ~ $ 10.00 | SPK – SPK Acquisition Corp. (Announced)
-.31% ~ $ 9.66 | IPAX – Inflection Point Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.74 | TCVA – TCV Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.75 | EGGF – EG Acquisition Corp. (Pre-Deal)
-.31% ~ $ 9.78 | GAQ – Generation Asia I Acquisition Ltd (Pre-Deal)
-.30% ~ $ 9.81 | ATAQ – Altimar Acquisition Corp. III (Pre-Deal)
-.30% ~ $ 9.85 | AKIC – Sports Ventures Acquisition Corp. (Pre-Deal)
-.30% ~ $ 9.86 | RFAC – RF Acquisition Corp. (Pre-Deal)
-.30% ~ $ 9.92 | CFFS – CF Acquisition Corp. VII (Pre-Deal)
-.30% ~ $ 9.98 | BMAC – Black Mountain Acquisition Corp. (Pre-Deal)
-.30% ~ $ 10.01 | ADRT – Ault Disruptive Technologies Corp (Pre-Deal)
-.30% ~ $ 10.03 | GOGN – GoGreen Investments Corp (Pre-Deal)

<a href="https://www.boardroomalpha.com/author/draps/" target="_self">David Drapkin</a>

David Drapkin

Spent his formative years at Goldman Sachs and now embraces the start-up life in NYC. A long suffering Oakland (Las Vegas) Raiders fan and graduate of the Wharton School at the University of Pennsylvania. Semi-professional go-kart racer waiting for his shot.

Know Who Drives Return

Objective, data-driven assessments for every public company director and officer.

SPAC Analytics & Database

Comprehensive research and analytics on every SPAC, sponsor, and deal. Real-time alerts, yields, red flags, filings, investors, and much more. API access to institutional grade SPAC database.

Monthly SPAC Review

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

SPAC Research & Analysis

Investing in SPACs for Yield with Jonathan Browne from Robinson Capital

Jonathan Browne from Robinson Capital joins Boardroom Alpha’s David Drapkin to talk about SPAC arbitrage. Robinson Capital’s SPAX ETF launched in June of 2021 and is an actively managed exchange-trade fund (ETF) that invests in Special Purpose Acquisition Companies (SPACs), also known as blank check companies. SPAX seeks to provide total return while minimizing downside risk.

SPACs, FOMO, and Tail Risk – Matthew Tuttle Captures the Momentum

Matthew Tuttle from Tuttle Capital joins David Drapkin to talk about SPACs, FOMO, and tail risk. Tuttle Capital’s thematic and actively managed ETFs are taking advantage of the SPAC craze, everybody’s FOMO (fear of missing out), and protecting the downside tail risk.

Kyle Bransfield and Ruben Minski on the Union Acquisition II / Procaps SPAC Deal

Boardroom Alpha’s David Drapkin welcomes Union Acquisition II CEO Kyle Bransfield and Procaps CEO Ruben Minski to the podcast. The deal goes to vote on September 22, 2021 and ex-redemption on September 17, so this will be one of shareholders’ last opportunities to hear from the team before deciding to redeem or go long alongside Kyle and Ruben.

Know Who Drives Return Podcast

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.